Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06576297 · ClinicalTrials.gov registry record · NA

Novel Respiratory Training as Part of Palliative Care for Older Adults With Heart Failure

A NA study of Aging and Quality of Life, sponsored by University of Pittsburgh.

Active
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06576297: Active NA study of Aging and Quality of Life, sponsored by University of Pittsburgh.

NCT06576297 is a NA study of Aging and Quality of Life that is active but no longer recruiting, run by University of Pittsburgh. The registered enrollment target is 30 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06576297, a NA study of Aging and Quality of Life, is active but no longer recruiting, sponsored by University of Pittsburgh.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

In a randomized controlled trial, to study the utility of inspiratory muscle training (IMT) to improve functional outcomes in adults aged ≥70 years with heart failure (HF) who have been referred to palliative care for end-stage HF management. * The study team hypothesize that older HF patients will be able to use IMT safely, reliably, and effectively in a 12-week home-based training regimen. * The study team hypothesize that physical function (sit to stand, gait speed, grip strength), respiratory/pulmonary function, self-efficacy, fatigue and quality of life will increase among older HF patients randomized IMT versus those randomized to usual care.

Primary Outcome

The number of participants who complete the 3-month assessment is used as a measure of intervention feasibility. Completion of this assessment indicates the feasibility of retaining participants in the study throughout the 3-month intervention period.

Interventions

  • OTHER Standard of Care
  • OTHER Inspiratory Muscle Training (IMT)

Study Locations (1)

Pennsylvania

  • University of Pittsburgh - Pittsburgh

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2024-06-30
Est. Completion 2026-02-28
Phase NA
University of Pittsburgh

1,238 total trials

What the registry record for NCT06576297 still lists

NCT06576297 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower).

The record links to 6 conditions, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Standard of Care is the first listed.

NCT06576297 reports a single indexed study location in Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT06576297 about?

NCT06576297 is a clinical study titled "Novel Respiratory Training as Part of Palliative Care for Older Adults With Heart Failure". In a randomized controlled trial, to study the utility of inspiratory muscle training (IMT) to improve functional outcomes in adults aged ≥70 years with heart failure (HF) who have been referred to palliative care for end-stage HF management. * The study team hypothesize that older HF patients will...

What is the current status of trial NCT06576297?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2024-06-30. Estimated completion is 2026-02-28.

What conditions does trial NCT06576297 study?

This clinical trial studies the following conditions: Aging, Quality of Life, Frailty, Heart Failure With Preserved Ejection Fraction, Heart Failure With Reduced Ejection Fraction.

What interventions are being tested in trial NCT06576297?

The interventions under investigation include: Standard of Care (OTHER), Inspiratory Muscle Training (IMT) (OTHER).

Who is sponsoring clinical trial NCT06576297?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06576297 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06576297's enrollment target sits among peer trials

30 193rd of 262 higher than 60 of 262 other Aging trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06576297, the US trial registry maintained by the National Library of Medicine. NCT06576297 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.